SUVEN LIFE SCIENCES LTD. - 530239 - Compliance Certificate For The Year Ended 31St March, 2024
Compliance Certificate under Reg 7(3) for the year ended 31st March, 202415-04-2024
15-04-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Compliance Certificate Under Regulation 40(10) For The Year Ended 31St March, 2024
Please find enclosed Compliance Certificate under Regulation 40(10) for the year ended 31st March, 202415-04-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Suven Life Sciences to present Phase-2 Positive Results on Samelisant (SUVN-G3031) at American Academy of Neurology (AAN) 2024 Annual Meeting, Denver, USA.15-04-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Certificate in terms of Regulation 74(5) of SEBI (DP) Regulations 201805-04-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Closure of Trading Window
Closure of Trading Window from April 01, 202427-03-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Scrutinizer"s Report
Enclosed herewith Scrutinizer report along with outcome of postal ballot.05-03-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Shareholder Meeting / Postal Ballot-Outcome of Postal Ballot
Outcome of Postal Ballot05-03-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Please find enclosed News Release of our company06-02-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Monitoring Agency Report
Enclosed herewith Monitoring Agency report for quarter ended December 31, 202305-02-2024
SUVEN LIFE SCIENCES LTD. - 530239 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Enclosed copies of newspaper advertisement regarding Postal Ballot Notice03-02-2024